Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Edit Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Emmaus Life Sciences, Inc. - Common Stock
(OP:
EMMA
)
0.0230
+0.0080 (+53.33%)
Delayed Quote
Updated: 12:50 PM EST, Nov 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Emmaus Life Sciences, Inc. - Common Stock
Emmaus Life Sciences Advances Middle East Strategy with Real-World Evidence Initiatives and Expansion into Africa
November 12, 2026
From
Emmaus Life Sciences, Inc.
Via
Business Wire
Emmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic Cancer
August 31, 2026
From
Emmaus Life Sciences, Inc.
Via
Business Wire
Emmaus Life Sciences Reports Quarterly Financial Results
August 14, 2026
From
Emmaus Life Sciences, Inc.
Via
Business Wire
Emmaus Life Sciences Reports Quarterly Financial Results
May 15, 2026
From
Emmaus Life Sciences, Inc.
Via
Business Wire
Emmaus Life Sciences Reports Annual Financial Results
March 30, 2026
From
Emmaus Life Sciences, Inc.
Via
Business Wire
Emmaus Life Sciences Announces Strategic Transaction
December 30, 2025
From
Emmaus Life Sciences, Inc.
Via
Business Wire
The Leading Emerging Markets For Market-Beating Gains in 2024
August 25, 2023
Emerging markets are expected to outperform over the next year and will be led by countries like Brazil and India, if for different reasons.
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.